Abnormal kynurenine pathway of tryptophan catabolism in cardiovascular diseases
Kynurenine pathway (KP) is the primary path of tryptophan (Trp) catabolism in most
mammalian cells. The KP generates several bioactive catabolites, such as kynurenine (Kyn) …
mammalian cells. The KP generates several bioactive catabolites, such as kynurenine (Kyn) …
Matrix metalloproteinase in abdominal aortic aneurysm and aortic dissection
Abdominal Aortic Aneurysm (AAA) affects 4–5% of men over 65, and Aortic Dissection (AD)
is a life-threatening aortic pathology associated with high morbidity and mortality. Initiators of …
is a life-threatening aortic pathology associated with high morbidity and mortality. Initiators of …
Novel aspects of the pathogenesis of aneurysms of the abdominal aorta in humans
JB Michel, JL Martin-Ventura, J Egido… - Cardiovascular …, 2011 - academic.oup.com
Aneurysm of the abdominal aorta (AAA) is a particular, specifically localized form of
atherothrombosis, providing a unique human model of this disease. The pathogenesis of …
atherothrombosis, providing a unique human model of this disease. The pathogenesis of …
Pharmacologic management of aneurysms
JH Lindeman, JS Matsumura - Circulation research, 2019 - Am Heart Assoc
Current management of aortic aneurysms relies exclusively on prophylactic operative repair
of larger aneurysms. Great potential exists for successful medical therapy that halts or …
of larger aneurysms. Great potential exists for successful medical therapy that halts or …
Clinical trial of doxycycline for matrix metalloproteinase-9 inhibition in patients with an abdominal aneurysm: doxycycline selectively depletes aortic wall neutrophils …
JHN Lindeman, H Abdul-Hussien, JH van Bockel… - Circulation, 2009 - Am Heart Assoc
Background—Doxycycline has been shown to effectively inhibit aneurysm formation in
animal models of abdominal aortic aneurysm. Although this effect is ascribed to matrix …
animal models of abdominal aortic aneurysm. Although this effect is ascribed to matrix …
Matrix metalloproteinase inhibition therapy for vascular diseases
AC Newby - Vascular pharmacology, 2012 - Elsevier
The matrix metalloproteinases (MMPs) are 23 secreted or cell surface proteases that act
together and with other protease classes to turn over the extracellular matrix, cleave cell …
together and with other protease classes to turn over the extracellular matrix, cleave cell …
Cystatin C: an emerging biomarker in cardiovascular disease
C Angelidis, S Deftereos… - Current topics in …, 2013 - ingentaconnect.com
Cystatin C (cys-C) is a small protein molecule (120 amino acid peptide chain, approximately
13kDa) produced by virtually all nucleated cells in the human body. It belongs to the family …
13kDa) produced by virtually all nucleated cells in the human body. It belongs to the family …
The peri-islet basement membrane, a barrier to infiltrating leukocytes in type 1 diabetes in mouse and human
We provide the first comprehensive analysis of the extracellular matrix (ECM) composition of
peri-islet capsules, composed of the peri-islet basement membrane (BM) and subjacent …
peri-islet capsules, composed of the peri-islet basement membrane (BM) and subjacent …
Novel pharmacological approaches in abdominal aortic aneurysm
L Puertas-Umbert, R Almendra-Pegueros… - Clinical …, 2023 - portlandpress.com
Abdominal aortic aneurysm (AAA) is a severe vascular disease and a major public health
issue with an unmet medical need for therapy. This disease is featured by a progressive …
issue with an unmet medical need for therapy. This disease is featured by a progressive …
Biomarkers of AAA progression. Part 1: extracellular matrix degeneration
FA Hellenthal, WA Buurman, WKWH Wodzig… - Nature Reviews …, 2009 - nature.com
Abdominal aortic aneurysm (AAA) is an important health problem. Elective surgical
treatment is recommended on the basis of an individual's risk of rupture, which is predicted …
treatment is recommended on the basis of an individual's risk of rupture, which is predicted …